312 related articles for article (PubMed ID: 37328875)
1. Role and clinical implication of autophagy in COVID-19.
Shan T; Li LY; Yang JM; Cheng Y
Virol J; 2023 Jun; 20(1):125. PubMed ID: 37328875
[TBL] [Abstract][Full Text] [Related]
2. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
3. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
[TBL] [Abstract][Full Text] [Related]
4. Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.
He W; Gao Y; Zhou J; Shi Y; Xia D; Shen HM
Int J Biol Sci; 2022; 18(12):4690-4703. PubMed ID: 35874956
[TBL] [Abstract][Full Text] [Related]
5. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
6. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
Bello-Perez M; Sola I; Novoa B; Klionsky DJ; Falco A
Cells; 2020 Jul; 9(7):. PubMed ID: 32635598
[TBL] [Abstract][Full Text] [Related]
7. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT
mBio; 2021 Jan; 12(1):. PubMed ID: 33468703
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
9. Molecular Virology of SARS-CoV-2 and Related Coronaviruses.
Kung YA; Lee KM; Chiang HJ; Huang SY; Wu CJ; Shih SR
Microbiol Mol Biol Rev; 2022 Jun; 86(2):e0002621. PubMed ID: 35343760
[TBL] [Abstract][Full Text] [Related]
10. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
11. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
12. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
14. Autophagy in Inflammatory Response against SARS-CoV-2.
Resnik R; Lopez Mingorance F; Rivera F; Mitchell F; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902354
[TBL] [Abstract][Full Text] [Related]
15. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Cloherty APM; Rader AG; Patel KS; Pérez-Vargas J; Thompson CAH; Ennis S; Niikura M; Wildenberg ME; Muncan V; Schreurs RRCE; Jean F; Ribeiro CMS
Emerg Microbes Infect; 2023 Dec; 12(1):2195020. PubMed ID: 36951188
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional interplay between SARS-CoV-2 and autophagy.
Zhou H; Hu Z; Castro-Gonzalez S
mBio; 2023 Aug; 14(4):e0102023. PubMed ID: 37436071
[TBL] [Abstract][Full Text] [Related]
17. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
18. Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19.
Chen Y; Xue Y; Yang J
J Med Virol; 2023 Mar; 95(3):e28592. PubMed ID: 36806030
[TBL] [Abstract][Full Text] [Related]
19. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.
Kumari M; Lu RM; Li MC; Huang JL; Hsu FF; Ko SH; Ke FY; Su SC; Liang KH; Yuan JP; Chiang HL; Sun CP; Lee IJ; Li WS; Hsieh HP; Tao MH; Wu HC
J Biomed Sci; 2022 Sep; 29(1):68. PubMed ID: 36096815
[TBL] [Abstract][Full Text] [Related]
20. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
Siri M; Dastghaib S; Zamani M; Rahmani-Kukia N; Geraylow KR; Fakher S; Keshvarzi F; Mehrbod P; Ahmadi M; Mokarram P; Coombs KM; Ghavami S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
